HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells
- PMID: 16093308
- PMCID: PMC1189347
- DOI: 10.1073/pnas.0505624102
HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells
Abstract
Genetic manipulation of hematopoietic stem and progenitor cells is an important tool for experimental and clinical applied hematology. However, techniques that allow for gene targeting, subsequent in vitro selection, and expansion of genetically defined clones are available only for ES cells. Such molecularly defined and, hence, "safe" clones would be highly desirable for somatic gene therapy. Here, we demonstrate that in vitro differentiated ES cells completely recapitulate the growth and differentiation properties of adult bone marrow cells, in vitro and in vivo, when ectopically expressing HOXB4. Myeloid development was enforced and (T) lymphoid development suppressed over a wide range of expression levels, whereas only high expression levels of the transcription factor were detrimental for erythroid development. This indicates a close association between the amounts of ectopic HOXB4 present within a progenitor cell and and the decision to self renew or differentiate. Because HOXB4 mediates similar fates of ES-derived and bone marrow hematopoietic stem cells, the primitive embryonic cells can be considered a promising alternative for investigating hematopoietic reconstitution, in vivo, based on well defined clones. Provided that HOXB4 levels are kept within a certain therapeutic window, ES cells also carry the potential of efficient and safe somatic gene therapy.
Figures




Similar articles
-
Development of hematopoietic stem and progenitor cells from mouse embryonic stem cells, in vitro, supported by ectopic human HOXB4 expression.Methods Mol Biol. 2013;1029:129-47. doi: 10.1007/978-1-62703-478-4_10. Methods Mol Biol. 2013. PMID: 23756947
-
Promotion of hematopoietic differentiation from mouse induced pluripotent stem cells by transient HoxB4 transduction.Stem Cell Res. 2012 Mar;8(2):300-11. doi: 10.1016/j.scr.2011.09.001. Epub 2011 Sep 16. Stem Cell Res. 2012. PMID: 22000550
-
Manipulation of immune system via immortal bone marrow stem cells.Int Immunol. 2008 Sep;20(9):1211-8. doi: 10.1093/intimm/dxn079. Epub 2008 Jul 21. Int Immunol. 2008. PMID: 18644831
-
Control of self-renewal and differentiation of hematopoietic stem cells: HOXB4 on the threshold.Ann N Y Acad Sci. 2005 Jun;1044:6-15. doi: 10.1196/annals.1349.002. Ann N Y Acad Sci. 2005. PMID: 15958692 Review.
-
[Ex vivo expansion of human hematopoietic stem/progenitor cells by TAT-HOXB4 homeoprotein and the prospect of its clinical use].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Apr;21(2):489-92. doi: 10.7534/j.issn.1009-2137.2013.02.049. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 23628061 Review. Chinese.
Cited by
-
In Vitro Generation of Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature from Murine Induced Pluripotent Stem Cells.Stem Cell Reports. 2017 Apr 11;8(4):919-932. doi: 10.1016/j.stemcr.2017.03.001. Epub 2017 Mar 30. Stem Cell Reports. 2017. PMID: 28366456 Free PMC article.
-
Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells.Blood. 2010 Aug 5;116(5):711-9. doi: 10.1182/blood-2009-07-235341. Epub 2010 Apr 14. Blood. 2010. PMID: 20393131 Free PMC article.
-
Designer blood: creating hematopoietic lineages from embryonic stem cells.Blood. 2006 Feb 15;107(4):1265-75. doi: 10.1182/blood-2005-09-3621. Epub 2005 Oct 27. Blood. 2006. PMID: 16254136 Free PMC article. Review.
-
Genesis of hematopoietic stem cells in vitro and in vivo: new insights into developmental maturation.Int J Hematol. 2005 May;81(4):275-80. doi: 10.1532/ijh97.04192. Int J Hematol. 2005. PMID: 16010731 Review.
-
Embryonic stem cell-derived hematopoietic stem cells.Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19081-6. doi: 10.1073/pnas.0506127102. Epub 2005 Dec 15. Proc Natl Acad Sci U S A. 2005. PMID: 16357205 Free PMC article.
References
-
- Glimm, H., Oh, I. H. & Eaves, C. J. (2000) Blood 96, 4185–4193. - PubMed
-
- Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A. & Weissman, I. L. (2003) Annu. Rev. Immunol. 21, 759–806. - PubMed
-
- Just, U., Stocking, C., Spooncer, E., Dexter, T. M. & Ostertag, W. (1991) Cell 64, 1163–1173. - PubMed
-
- Zhang, J., Niu, C., Ye, L., Huang, H., He, X., Tong, W. G., Ross, J., Haug, J., Johnson, T., Feng, J. Q., et al. (2003) Nature 425, 836–841. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical